Search

Your search keyword '"Mahadevan, Daruka"' showing total 46 results
Start Over Author "Mahadevan, Daruka" Publisher american association for cancer research (aacr)
46 results on '"Mahadevan, Daruka"'

2. Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Author

Fong, Lawrence, primary, Hotson, Andrew, primary, Powderly, John D., primary, Sznol, Mario, primary, Heist, Rebecca S., primary, Choueiri, Toni K., primary, George, Saby, primary, Hughes, Brett G.M., primary, Hellmann, Matthew D., primary, Shepard, Dale R., primary, Rini, Brian I., primary, Kummar, Shivaani, primary, Weise, Amy M., primary, Riese, Matthew J., primary, Markman, Ben, primary, Emens, Leisha A., primary, Mahadevan, Daruka, primary, Luke, Jason J., primary, Laport, Ginna, primary, Brody, Joshua D., primary, Hernandez-Aya, Leonel, primary, Bonomi, Philip, primary, Goldman, Jonathan W., primary, Berim, Lyudmyla, primary, Renouf, Daniel J., primary, Goodwin, Rachel A., primary, Munneke, Brian, primary, Ho, Po Y., primary, Hsieh, Jessica, primary, McCaffery, Ian, primary, Kwei, Long, primary, Willingham, Stephen B., primary, and Miller, Richard A., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Author

Fong, Lawrence, primary, Hotson, Andrew, primary, Powderly, John D., primary, Sznol, Mario, primary, Heist, Rebecca S., primary, Choueiri, Toni K., primary, George, Saby, primary, Hughes, Brett G.M., primary, Hellmann, Matthew D., primary, Shepard, Dale R., primary, Rini, Brian I., primary, Kummar, Shivaani, primary, Weise, Amy M., primary, Riese, Matthew J., primary, Markman, Ben, primary, Emens, Leisha A., primary, Mahadevan, Daruka, primary, Luke, Jason J., primary, Laport, Ginna, primary, Brody, Joshua D., primary, Hernandez-Aya, Leonel, primary, Bonomi, Philip, primary, Goldman, Jonathan W., primary, Berim, Lyudmyla, primary, Renouf, Daniel J., primary, Goodwin, Rachel A., primary, Munneke, Brian, primary, Ho, Po Y., primary, Hsieh, Jessica, primary, McCaffery, Ian, primary, Kwei, Long, primary, Willingham, Stephen B., primary, and Miller, Richard A., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Author

Fong, Lawrence, primary, Hotson, Andrew, primary, Powderly, John D., primary, Sznol, Mario, primary, Heist, Rebecca S., primary, Choueiri, Toni K., primary, George, Saby, primary, Hughes, Brett G.M., primary, Hellmann, Matthew D., primary, Shepard, Dale R., primary, Rini, Brian I., primary, Kummar, Shivaani, primary, Weise, Amy M., primary, Riese, Matthew J., primary, Markman, Ben, primary, Emens, Leisha A., primary, Mahadevan, Daruka, primary, Luke, Jason J., primary, Laport, Ginna, primary, Brody, Joshua D., primary, Hernandez-Aya, Leonel, primary, Bonomi, Philip, primary, Goldman, Jonathan W., primary, Berim, Lyudmyla, primary, Renouf, Daniel J., primary, Goodwin, Rachel A., primary, Munneke, Brian, primary, Ho, Po Y., primary, Hsieh, Jessica, primary, McCaffery, Ian, primary, Kwei, Long, primary, Willingham, Stephen B., primary, and Miller, Richard A., primary

Published
2023
Full Text
View/download PDF

5. Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Author

Fong, Lawrence, primary, Hotson, Andrew, primary, Powderly, John D., primary, Sznol, Mario, primary, Heist, Rebecca S., primary, Choueiri, Toni K., primary, George, Saby, primary, Hughes, Brett G.M., primary, Hellmann, Matthew D., primary, Shepard, Dale R., primary, Rini, Brian I., primary, Kummar, Shivaani, primary, Weise, Amy M., primary, Riese, Matthew J., primary, Markman, Ben, primary, Emens, Leisha A., primary, Mahadevan, Daruka, primary, Luke, Jason J., primary, Laport, Ginna, primary, Brody, Joshua D., primary, Hernandez-Aya, Leonel, primary, Bonomi, Philip, primary, Goldman, Jonathan W., primary, Berim, Lyudmyla, primary, Renouf, Daniel J., primary, Goodwin, Rachel A., primary, Munneke, Brian, primary, Ho, Po Y., primary, Hsieh, Jessica, primary, McCaffery, Ian, primary, Kwei, Long, primary, Willingham, Stephen B., primary, and Miller, Richard A., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Data from Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)

Author

Babiker, Hani, primary, Borazanci, Erkut, primary, Subbiah, Vivek, primary, Agarwala, Sanjiv, primary, Algazi, Alain, primary, Schachter, Jacob, primary, Lotem, Michael, primary, Maurice-Dror, Corinne, primary, Hendler, Daniel, primary, Rahimian, Shah, primary, Minderman, Hans, primary, Haymaker, Cara, primary, Mahadevan, Daruka, primary, Bernatchez, Chantale, primary, Murthy, Ravi, primary, Hultsch, Rolf, primary, Kaplan, Nadia, primary, Woodhead, Gregory, primary, Hennemeyer, Charles, primary, Chunduru, Srinivas, primary, Anderson, Peter M., primary, Diab, Adi, primary, and Puzanov, Igor, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Data from Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)

Author

Babiker, Hani, primary, Borazanci, Erkut, primary, Subbiah, Vivek, primary, Agarwala, Sanjiv, primary, Algazi, Alain, primary, Schachter, Jacob, primary, Lotem, Michael, primary, Maurice-Dror, Corinne, primary, Hendler, Daniel, primary, Rahimian, Shah, primary, Minderman, Hans, primary, Haymaker, Cara, primary, Mahadevan, Daruka, primary, Bernatchez, Chantale, primary, Murthy, Ravi, primary, Hultsch, Rolf, primary, Kaplan, Nadia, primary, Woodhead, Gregory, primary, Hennemeyer, Charles, primary, Chunduru, Srinivas, primary, Anderson, Peter M., primary, Diab, Adi, primary, and Puzanov, Igor, primary

Published
2023
Full Text
View/download PDF

8. Appendix figures from Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, primary, Paz-Ares, Luis G., primary, Garrido, Pilar, primary, Jalal, Shadia, primary, Mahadevan, Daruka, primary, Gutierrez, Martin, primary, Provencio, Mariano, primary, Schaefer, Eric, primary, Shaheen, Monte, primary, Johnston, Erica L., primary, Turner, P. Kellie, primary, Kambhampati, Siva Rama Prasad, primary, Beckmann, Richard, primary, Hossain, Anwar, primary, John, William J., primary, and Goldman, Jonathan W., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 1 from Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma

Author

Zullo, Kelly M., primary, Guo, Yige, primary, Cooke, Laurence, primary, Jirau-Serrano, Xavier, primary, Mangone, Michael, primary, Scotto, Luigi, primary, Amengual, Jennifer E., primary, Mao, Yinghui, primary, Nandakumar, Renu, primary, Cremers, Serge, primary, Duong, Jimmy, primary, Mahadevan, Daruka, primary, and O'Connor, Owen A., primary

Published
2023
Full Text
View/download PDF

10. Appendix text from Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, primary, Paz-Ares, Luis G., primary, Garrido, Pilar, primary, Jalal, Shadia, primary, Mahadevan, Daruka, primary, Gutierrez, Martin, primary, Provencio, Mariano, primary, Schaefer, Eric, primary, Shaheen, Monte, primary, Johnston, Erica L., primary, Turner, P. Kellie, primary, Kambhampati, Siva Rama Prasad, primary, Beckmann, Richard, primary, Hossain, Anwar, primary, John, William J., primary, and Goldman, Jonathan W., primary

Published
2023
Full Text
View/download PDF

11. Figure S2 from Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Author

Kelly, Kevin R., primary, Friedberg, Jonathan W., primary, Park, Steven I., primary, McDonagh, Kevin, primary, Hayslip, John, primary, Persky, Daniel, primary, Ruan, Jia, primary, Puvvada, Soham, primary, Rosen, Peter, primary, Iyer, Swaminathan Padmanabhan, primary, Stefanovic, Alexandra, primary, Bernstein, Steven H., primary, Weitman, Steven, primary, Karnad, Anand, primary, Monohan, Gregory, primary, VanderWalde, Ari, primary, Mena, Raul, primary, Schmelz, Monika, primary, Spier, Catherine, primary, Groshen, Susan, primary, Venkatakrishnan, Karthik, primary, Zhou, Xiaofei, primary, Sheldon-Waniga, Emily, primary, Leonard, E. Jane, primary, and Mahadevan, Daruka, primary

Published
2023
Full Text
View/download PDF

12. Figure S1 from Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Author

Kelly, Kevin R., primary, Friedberg, Jonathan W., primary, Park, Steven I., primary, McDonagh, Kevin, primary, Hayslip, John, primary, Persky, Daniel, primary, Ruan, Jia, primary, Puvvada, Soham, primary, Rosen, Peter, primary, Iyer, Swaminathan Padmanabhan, primary, Stefanovic, Alexandra, primary, Bernstein, Steven H., primary, Weitman, Steven, primary, Karnad, Anand, primary, Monohan, Gregory, primary, VanderWalde, Ari, primary, Mena, Raul, primary, Schmelz, Monika, primary, Spier, Catherine, primary, Groshen, Susan, primary, Venkatakrishnan, Karthik, primary, Zhou, Xiaofei, primary, Sheldon-Waniga, Emily, primary, Leonard, E. Jane, primary, and Mahadevan, Daruka, primary

Published
2023
Full Text
View/download PDF

13. Figure S1 from Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Author

Kelly, Kevin R., primary, Friedberg, Jonathan W., primary, Park, Steven I., primary, McDonagh, Kevin, primary, Hayslip, John, primary, Persky, Daniel, primary, Ruan, Jia, primary, Puvvada, Soham, primary, Rosen, Peter, primary, Iyer, Swaminathan Padmanabhan, primary, Stefanovic, Alexandra, primary, Bernstein, Steven H., primary, Weitman, Steven, primary, Karnad, Anand, primary, Monohan, Gregory, primary, VanderWalde, Ari, primary, Mena, Raul, primary, Schmelz, Monika, primary, Spier, Catherine, primary, Groshen, Susan, primary, Venkatakrishnan, Karthik, primary, Zhou, Xiaofei, primary, Sheldon-Waniga, Emily, primary, Leonard, E. Jane, primary, and Mahadevan, Daruka, primary

Published
2023
Full Text
View/download PDF

14. Appendix tables from Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, primary, Paz-Ares, Luis G., primary, Garrido, Pilar, primary, Jalal, Shadia, primary, Mahadevan, Daruka, primary, Gutierrez, Martin, primary, Provencio, Mariano, primary, Schaefer, Eric, primary, Shaheen, Monte, primary, Johnston, Erica L., primary, Turner, P. Kellie, primary, Kambhampati, Siva Rama Prasad, primary, Beckmann, Richard, primary, Hossain, Anwar, primary, John, William J., primary, and Goldman, Jonathan W., primary

Published
2023
Full Text
View/download PDF

15. Figure S2 from Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Author

Kelly, Kevin R., primary, Friedberg, Jonathan W., primary, Park, Steven I., primary, McDonagh, Kevin, primary, Hayslip, John, primary, Persky, Daniel, primary, Ruan, Jia, primary, Puvvada, Soham, primary, Rosen, Peter, primary, Iyer, Swaminathan Padmanabhan, primary, Stefanovic, Alexandra, primary, Bernstein, Steven H., primary, Weitman, Steven, primary, Karnad, Anand, primary, Monohan, Gregory, primary, VanderWalde, Ari, primary, Mena, Raul, primary, Schmelz, Monika, primary, Spier, Catherine, primary, Groshen, Susan, primary, Venkatakrishnan, Karthik, primary, Zhou, Xiaofei, primary, Sheldon-Waniga, Emily, primary, Leonard, E. Jane, primary, and Mahadevan, Daruka, primary

Published
2023
Full Text
View/download PDF

16. Video 1 from Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma

Author

Zullo, Kelly M., primary, Guo, Yige, primary, Cooke, Laurence, primary, Jirau-Serrano, Xavier, primary, Mangone, Michael, primary, Scotto, Luigi, primary, Amengual, Jennifer E., primary, Mao, Yinghui, primary, Nandakumar, Renu, primary, Cremers, Serge, primary, Duong, Jimmy, primary, Mahadevan, Daruka, primary, and O'Connor, Owen A., primary

Published
2023
Full Text
View/download PDF

17. Appendix tables from Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, primary, Paz-Ares, Luis G., primary, Garrido, Pilar, primary, Jalal, Shadia, primary, Mahadevan, Daruka, primary, Gutierrez, Martin, primary, Provencio, Mariano, primary, Schaefer, Eric, primary, Shaheen, Monte, primary, Johnston, Erica L., primary, Turner, P. Kellie, primary, Kambhampati, Siva Rama Prasad, primary, Beckmann, Richard, primary, Hossain, Anwar, primary, John, William J., primary, and Goldman, Jonathan W., primary

Published
2023
Full Text
View/download PDF

18. Appendix figures from Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, primary, Paz-Ares, Luis G., primary, Garrido, Pilar, primary, Jalal, Shadia, primary, Mahadevan, Daruka, primary, Gutierrez, Martin, primary, Provencio, Mariano, primary, Schaefer, Eric, primary, Shaheen, Monte, primary, Johnston, Erica L., primary, Turner, P. Kellie, primary, Kambhampati, Siva Rama Prasad, primary, Beckmann, Richard, primary, Hossain, Anwar, primary, John, William J., primary, and Goldman, Jonathan W., primary

Published
2023
Full Text
View/download PDF

19. Appendix text from Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, primary, Paz-Ares, Luis G., primary, Garrido, Pilar, primary, Jalal, Shadia, primary, Mahadevan, Daruka, primary, Gutierrez, Martin, primary, Provencio, Mariano, primary, Schaefer, Eric, primary, Shaheen, Monte, primary, Johnston, Erica L., primary, Turner, P. Kellie, primary, Kambhampati, Siva Rama Prasad, primary, Beckmann, Richard, primary, Hossain, Anwar, primary, John, William J., primary, and Goldman, Jonathan W., primary

Published
2023
Full Text
View/download PDF

20. Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)

Author

Babiker, Hani, primary, Borazanci, Erkut, additional, Subbiah, Vivek, additional, Agarwala, Sanjiv, additional, Algazi, Alain, additional, Schachter, Jacob, additional, Lotem, Michael, additional, Maurice-Dror, Corinne, additional, Hendler, Daniel, additional, Rahimian, Shah, additional, Minderman, Hans, additional, Haymaker, Cara, additional, Mahadevan, Daruka, additional, Bernatchez, Chantale, additional, Murthy, Ravi, additional, Hultsch, Rolf, additional, Kaplan, Nadia, additional, Woodhead, Gregory, additional, Hennemeyer, Charles, additional, Chunduru, Srinivas, additional, Anderson, Peter M., additional, Diab, Adi, additional, and Puzanov, Igor, additional

Published
2022
Full Text
View/download PDF

21. Abstract CT128: A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC)

Author

Spigel, David R., primary, Whitehead, Zachary, additional, Kim, Young, additional, Szado, Tania, additional, McDonald, Anne, additional, Darbonne, Walter C., additional, Levy, Jonathan, additional, Borden, Eucharia, additional, Mahadevan, Daruka, additional, and VanderWalde, Ari, additional

Published
2022
Full Text
View/download PDF

23. Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Author

Fong, Lawrence, primary, Hotson, Andrew, additional, Powderly, John D., additional, Sznol, Mario, additional, Heist, Rebecca S., additional, Choueiri, Toni K., additional, George, Saby, additional, Hughes, Brett G.M., additional, Hellmann, Matthew D., additional, Shepard, Dale R., additional, Rini, Brian I., additional, Kummar, Shivaani, additional, Weise, Amy M., additional, Riese, Matthew J., additional, Markman, Ben, additional, Emens, Leisha A., additional, Mahadevan, Daruka, additional, Luke, Jason J., additional, Laport, Ginna, additional, Brody, Joshua D., additional, Hernandez-Aya, Leonel, additional, Bonomi, Philip, additional, Goldman, Jonathan W., additional, Berim, Lyudmyla, additional, Renouf, Daniel J., additional, Goodwin, Rachel A., additional, Munneke, Brian, additional, Ho, Po Y., additional, Hsieh, Jessica, additional, McCaffery, Ian, additional, Kwei, Long, additional, Willingham, Stephen B., additional, and Miller, Richard A., additional

Published
2020
Full Text
View/download PDF

25. Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Author

Kelly, Kevin R., primary, Friedberg, Jonathan W., additional, Park, Steven I., additional, McDonagh, Kevin, additional, Hayslip, John, additional, Persky, Daniel, additional, Ruan, Jia, additional, Puvvada, Soham, additional, Rosen, Peter, additional, Iyer, Swaminathan Padmanabhan, additional, Stefanovic, Alexandra, additional, Bernstein, Steven H., additional, Weitman, Steven, additional, Karnad, Anand, additional, Monohan, Gregory, additional, VanderWalde, Ari, additional, Mena, Raul, additional, Schmelz, Monika, additional, Spier, Catherine, additional, Groshen, Susan, additional, Venkatakrishnan, Karthik, additional, Zhou, Xiaofei, additional, Sheldon-Waniga, Emily, additional, Leonard, E. Jane, additional, and Mahadevan, Daruka, additional

Published
2018
Full Text
View/download PDF

26. Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Author

Kim, Edward S., primary, Kelly, Karen, additional, Paz-Ares, Luis G., additional, Garrido, Pilar, additional, Jalal, Shadia, additional, Mahadevan, Daruka, additional, Gutierrez, Martin, additional, Provencio, Mariano, additional, Schaefer, Eric, additional, Shaheen, Monte, additional, Johnston, Erica L., additional, Turner, P. Kellie, additional, Kambhampati, Siva Rama Prasad, additional, Beckmann, Richard, additional, Hossain, Anwar, additional, John, William J., additional, and Goldman, Jonathan W., additional

Published
2018
Full Text
View/download PDF

28. Abstract CT119: CPI-444, an oral adenosine A2a receptor (A2aR) antagonist, demonstrates clinical activity in patients with advanced solid tumors

Author

Emens, Leisha, primary, Powderly, John, additional, Fong, Lawrence, additional, Brody, Joshua, additional, Forde, Patrick, additional, Hellmann, Matthew, additional, Hughes, Brett, additional, Kummar, Shivaani, additional, Loi, Sherene, additional, Luke, Jason, additional, Mahadevan, Daruka, additional, Markman, Benjamin, additional, McCaffery, Ian, additional, Miller, Richard, additional, and Laport, Ginna, additional

Published
2017
Full Text
View/download PDF

30. Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma

Author

Zullo, Kelly M., primary, Guo, Yige, additional, Cooke, Laurence, additional, Jirau-Serrano, Xavier, additional, Mangone, Michael, additional, Scotto, Luigi, additional, Amengual, Jennifer E., additional, Mao, Yinghui, additional, Nandakumar, Renu, additional, Cremers, Serge, additional, Duong, Jimmy, additional, Mahadevan, Daruka, additional, and O'Connor, Owen A., additional

Published
2015
Full Text
View/download PDF

36. Abstract 1745: Translational medicine enables rapid early clinical development of AVL-292, a highly selective, orally available inhibitor of Bruton's tyrosine kinase, in a phase 1b clinical trial

Author

Westlin, William F., primary, Stiede, Kathryn, additional, Lounsbury, Heather, additional, Witowski, Steve, additional, Silver, Bruce, additional, Freed, Martin, additional, Mahadevan, Daruka, additional, Sharman, Jeff, additional, Harb, Wael A., additional, Petter, Russell, additional, Singh, Juswinder, additional, and Evans, Erica, additional

Published
2012
Full Text
View/download PDF

43. Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer

Author

Riley, Christopher J., primary, Engelhardt, Kevin P., additional, Saldanha, Jose W., additional, Qi, Wenqing, additional, Cooke, Laurence S., additional, Zhu, Yingting, additional, Narayan, Satya T., additional, Shakalya, Kishore, additional, Croce, Kimiko Della, additional, Georgiev, Ivan G., additional, Nagle, Raymond B., additional, Garewal, Harinder, additional, Von Hoff, Daniel D., additional, and Mahadevan, Daruka, additional

Published
2009
Full Text
View/download PDF

44. Discovery of a novel class of AKT pleckstrin homology domain inhibitors

Author

Mahadevan, Daruka, primary, Powis, Garth, additional, Mash, Eugene A., additional, George, Benjamin, additional, Gokhale, Vijay M., additional, Zhang, Shuxing, additional, Shakalya, Kishore, additional, Du-Cuny, Lei, additional, Berggren, Margareta, additional, Ali, M. Ahad, additional, Jana, Umasish, additional, Ihle, Nathan, additional, Moses, Sylvestor, additional, Franklin, Chloe, additional, Narayan, Satya, additional, Shirahatti, Nikhil, additional, and Meuillet, Emmanuelle J., additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results